186 related articles for article (PubMed ID: 25408830)
1. 1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain.
Demont EH; Bamborough P; Chung CW; Craggs PD; Fallon D; Gordon LJ; Grandi P; Hobbs CI; Hussain J; Jones EJ; Le Gall A; Michon AM; Mitchell DJ; Prinjha RK; Roberts AD; Sheppard RJ; Watson RJ
ACS Med Chem Lett; 2014 Nov; 5(11):1190-5. PubMed ID: 25408830
[TBL] [Abstract][Full Text] [Related]
2. GSK6853, a Chemical Probe for Inhibition of the BRPF1 Bromodomain.
Bamborough P; Barnett HA; Becher I; Bird MJ; Chung CW; Craggs PD; Demont EH; Diallo H; Fallon DJ; Gordon LJ; Grandi P; Hobbs CI; Hooper-Greenhill E; Jones EJ; Law RP; Le Gall A; Lugo D; Michon AM; Mitchell DJ; Prinjha RK; Sheppard RJ; Watson AJ; Watson RJ
ACS Med Chem Lett; 2016 Jun; 7(6):552-7. PubMed ID: 27326325
[TBL] [Abstract][Full Text] [Related]
3. Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of Proteins.
Igoe N; Bayle ED; Tallant C; Fedorov O; Meier JC; Savitsky P; Rogers C; Morias Y; Scholze S; Boyd H; Cunoosamy D; Andrews DM; Cheasty A; Brennan PE; Müller S; Knapp S; Fish PV
J Med Chem; 2017 Aug; 60(16):6998-7011. PubMed ID: 28714688
[TBL] [Abstract][Full Text] [Related]
4. Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor.
Palmer WS; Poncet-Montange G; Liu G; Petrocchi A; Reyna N; Subramanian G; Theroff J; Yau A; Kost-Alimova M; Bardenhagen JP; Leo E; Shepard HE; Tieu TN; Shi X; Zhan Y; Zhao S; Barton MC; Draetta G; Toniatti C; Jones P; Geck Do M; Andersen JN
J Med Chem; 2016 Feb; 59(4):1440-54. PubMed ID: 26061247
[TBL] [Abstract][Full Text] [Related]
5. The BRPF1 bromodomain is a molecular reader of di-acetyllysine.
Obi JO; Lubula MY; Cornilescu G; Henrickson A; McGuire K; Evans CM; Phillips M; Boyson SP; Demeler B; Markley JL; Glass KC
Curr Res Struct Biol; 2020; 2():104-115. PubMed ID: 33554132
[TBL] [Abstract][Full Text] [Related]
6. Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains.
Bouché L; Christ CD; Siegel S; Fernández-Montalván AE; Holton SJ; Fedorov O; Ter Laak A; Sugawara T; Stöckigt D; Tallant C; Bennett J; Monteiro O; Díaz-Sáez L; Siejka P; Meier J; Pütter V; Weiske J; Müller S; Huber KVM; Hartung IV; Haendler B
J Med Chem; 2017 May; 60(9):4002-4022. PubMed ID: 28402630
[TBL] [Abstract][Full Text] [Related]
7. Structure-based discovery of selective BRPF1 bromodomain inhibitors.
Zhu J; Zhou C; Caflisch A
Eur J Med Chem; 2018 Jul; 155():337-352. PubMed ID: 29902720
[TBL] [Abstract][Full Text] [Related]
8. Uncovering the non-histone interactome of the BRPF1 bromodomain using site-specific azide-acetyllysine photochemistry.
Barman S; Padhan J; Sudhamalla B
J Biol Chem; 2024 Jan; 300(1):105551. PubMed ID: 38072045
[TBL] [Abstract][Full Text] [Related]
9. The Chromatin Regulator BRPF3 Preferentially Activates the HBO1 Acetyltransferase but Is Dispensable for Mouse Development and Survival.
Yan K; You L; Degerny C; Ghorbani M; Liu X; Chen L; Li L; Miao D; Yang XJ
J Biol Chem; 2016 Feb; 291(6):2647-63. PubMed ID: 26677226
[TBL] [Abstract][Full Text] [Related]
10. Biological function and histone recognition of family IV bromodomain-containing proteins.
Lloyd JT; Glass KC
J Cell Physiol; 2018 Mar; 233(3):1877-1886. PubMed ID: 28500727
[TBL] [Abstract][Full Text] [Related]
11. Discovery, optimization and evaluation of 1-(indolin-1-yl)ethan-1-ones as novel selective TRIM24/BRPF1 bromodomain inhibitors.
Xiang Q; Luo G; Zhang C; Hu Q; Wang C; Wu T; Xu H; Hu J; Zhuang X; Zhang M; Wu S; Xu J; Zhang Y; Liu J; Xu Y
Eur J Med Chem; 2022 Jun; 236():114311. PubMed ID: 35385803
[TBL] [Abstract][Full Text] [Related]
12. Crystallization and preliminary X-ray diffraction analysis of the BRPF1 bromodomain in complex with its H2AK5ac and H4K12ac histone-peptide ligands.
Lubula MY; Poplawaski A; Glass KC
Acta Crystallogr F Struct Biol Commun; 2014 Oct; 70(Pt 10):1389-93. PubMed ID: 25286946
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of an atypical PHD finger in BRPF2 and its interaction with DNA.
Liu L; Qin S; Zhang J; Ji P; Shi Y; Wu J
J Struct Biol; 2012 Oct; 180(1):165-73. PubMed ID: 22820306
[TBL] [Abstract][Full Text] [Related]
14. Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies.
Igoe N; Bayle ED; Fedorov O; Tallant C; Savitsky P; Rogers C; Owen DR; Deb G; Somervaille TC; Andrews DM; Jones N; Cheasty A; Ryder H; Brennan PE; Müller S; Knapp S; Fish PV
J Med Chem; 2017 Jan; 60(2):668-680. PubMed ID: 28068087
[TBL] [Abstract][Full Text] [Related]
15. [BRPF2, a novel transcript of BRPF1 and their expression in mice tissues].
Guo F; Lin PR; Li YQ; Su XL; Wang DD; Zhou TH
Yi Chuan; 2013 Jan; 35(1):79-84. PubMed ID: 23357268
[TBL] [Abstract][Full Text] [Related]
16. Twenty Crystal Structures of Bromodomain and PHD Finger Containing Protein 1 (BRPF1)/Ligand Complexes Reveal Conserved Binding Motifs and Rare Interactions.
Zhu J; Caflisch A
J Med Chem; 2016 Jun; 59(11):5555-61. PubMed ID: 27167503
[TBL] [Abstract][Full Text] [Related]
17. Selective Targeting of Bromodomains of the Bromodomain-PHD Fingers Family Impairs Osteoclast Differentiation.
Meier JC; Tallant C; Fedorov O; Witwicka H; Hwang SY; van Stiphout RG; Lambert JP; Rogers C; Yapp C; Gerstenberger BS; Fedele V; Savitsky P; Heidenreich D; Daniels DL; Owen DR; Fish PV; Igoe NM; Bayle ED; Haendler B; Oppermann UCT; Buffa F; Brennan PE; Müller S; Gingras AC; Odgren PR; Birnbaum MJ; Knapp S
ACS Chem Biol; 2017 Oct; 12(10):2619-2630. PubMed ID: 28849908
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the Chromatin Regulator Gene BRPF1 Cause Syndromic Intellectual Disability and Deficient Histone Acetylation.
Yan K; Rousseau J; Littlejohn RO; Kiss C; Lehman A; Rosenfeld JA; Stumpel CTR; Stegmann APA; Robak L; Scaglia F; Nguyen TTM; Fu H; Ajeawung NF; Camurri MV; Li L; Gardham A; Panis B; Almannai M; Sacoto MJG; Baskin B; Ruivenkamp C; Xia F; Bi W; ; ; Cho MT; Potjer TP; Santen GWE; Parker MJ; Canham N; McKinnon M; Potocki L; MacKenzie JJ; Roeder ER; Campeau PM; Yang XJ
Am J Hum Genet; 2017 Jan; 100(1):91-104. PubMed ID: 27939640
[TBL] [Abstract][Full Text] [Related]
19. MOZ and MORF acetyltransferases: Molecular interaction, animal development and human disease.
Yang XJ
Biochim Biophys Acta; 2015 Aug; 1853(8):1818-26. PubMed ID: 25920810
[TBL] [Abstract][Full Text] [Related]
20. Integrated virtual screening and MD simulation approaches toward discovering potential inhibitors for targeting BRPF1 bromodomain in hepatocellular carcinoma.
Barman S; Bardhan I; Padhan J; Sudhamalla B
J Mol Graph Model; 2024 Jan; 126():108642. PubMed ID: 37797430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
